Cargando…
Nitric oxide-releasing prodrug triggers cancer cell death through deregulation of cellular redox balance()
JS-K is a nitric oxide (NO)-releasing prodrug of the O(2)-arylated diazeniumdiolate family that has demonstrated pronounced cytotoxicity and antitumor properties in a variety of cancer models both in vitro and in vivo. The current study of the metabolic actions of JS-K was undertaken to investigate...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757670/ https://www.ncbi.nlm.nih.gov/pubmed/24024144 http://dx.doi.org/10.1016/j.redox.2012.12.002 |